Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Treasury Shares (2023 - 2025)

Historic Treasury Shares for 60 Degrees Pharmaceuticals (SXTPW) over the last 3 years, with Q3 2025 value amounting to $7.6 million.

  • 60 Degrees Pharmaceuticals' Treasury Shares fell 2255.86% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year decrease of 2255.86%. This contributed to the annual value of $1.8 million for FY2024, which is 324692.91% up from last year.
  • According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Treasury Shares is $7.6 million, which was down 2255.86% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Treasury Shares ranged from a high of $9.8 million in Q3 2024 and a low of $52737.0 during Q4 2023
  • Moreover, its 3-year median value for Treasury Shares was $1.3 million (2024), whereas its average is $2.5 million.
  • Within the past 5 years, the most significant YoY rise in 60 Degrees Pharmaceuticals' Treasury Shares was 361610.98% (2024), while the steepest drop was 5630.4% (2024).
  • Quarter analysis of 3 years shows 60 Degrees Pharmaceuticals' Treasury Shares stood at $52737.0 in 2023, then soared by 3246.93% to $1.8 million in 2024, then soared by 329.87% to $7.6 million in 2025.
  • Its Treasury Shares was $7.6 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.1 million in Q1 2025.